ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ORMP Oramed Pharmaceuticals Inc

2.35
0.005 (0.21%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Oramed Pharmaceuticals Inc NASDAQ:ORMP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.005 0.21% 2.35 2.17 2.41 2.45 2.35 2.38 64,697 23:00:01

Initial Statement of Beneficial Ownership (3)

19/07/2019 5:12pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Xiaoming Gao

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/1/2019 

3. Issuer Name and Ticker or Trading Symbol

ORAMED PHARMACEUTICALS INC. [ORMP]

(Last)        (First)        (Middle)

11F. NO. 266 HANKOU ROAD, HUANGPU DISTRICT

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

SHANGHAI, F4 2000001       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   1155367   I   (1) By Hefei Tianhui Incubator of Technologies Co., Ltd.  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Mr. Gao is an indirect beneficial owner and chairman of Hefei Tianhui Incubator of Technologies Co., Ltd. ("HTIT"). HTIT holds 1,155,367 shares of common stock of the issuer. Mr. Gao disclaims beneficial ownership in the securities owned by HTIT except to the extent, if any, of his pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Xiaoming Gao
11F. NO. 266 HANKOU ROAD
HUANGPU DISTRICT
SHANGHAI, F4 2000001
X



Signatures
/s/ Xiaoming Gao 7/19/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Oramed Pharmaceuticals Chart

1 Year Oramed Pharmaceuticals Chart

1 Month Oramed Pharmaceuticals Chart

1 Month Oramed Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock